What is Palforzia Oral Immunotherapy
Palforzia is a FDA-approved treatment for peanut allergy that uses oral immunotherapy (OIT) to desensitize patients to peanuts. The therapy involves gradually increasing doses of peanut protein over time, which helps the body build tolerance to the allergen.
The process typically starts with very small amounts and progresses through several stages, culminating in a maintenance dose that is intended to prevent allergic reactions when consuming peanuts.
How Palforzia Works
Palforzia works by exposing patients to increasing doses of peanut protein over time. This gradual exposure helps the immune system become less reactive to peanuts, reducing the risk of an allergic reaction when consuming them.
The treatment is designed with a specific dose-escalation schedule that increases the amount of peanut protein in each dose, starting from 3 mg and reaching up to 300 mg over six months. Simultaneously, the reactivity threshold is raised from 2 mg to 1000 mg over 24 months.
Why It Matters
Palforzia represents a significant advancement in managing peanut allergies by providing a structured and monitored approach to desensitization. This therapy can improve quality of life for those with peanut allergy, allowing them to consume peanuts without fear of an allergic reaction.
Moreover, it offers a non-invasive alternative to other forms of immunotherapy, such as subcutaneous injections, which can be more challenging for patients and healthcare providers.
Real-World Examples
A study published in the New England Journal of Medicine demonstrated that 82% of participants who completed the Palforzia treatment program were able to consume at least 10 grams of peanuts without experiencing an allergic reaction, compared to only 4% before starting the therapy.
Another study showed that patients treated with Palforzia had a significantly reduced risk of having severe allergic reactions when accidentally exposed to peanuts.
Frequently asked questions
How long does it take to complete the Palforzia treatment program?
The full Palforzia treatment program typically takes about 24 months, including an initial desensitization phase and a maintenance phase.
Is Palforzia suitable for all peanut allergy patients?
Palforzia is not recommended for everyone. It is generally prescribed to children and adults with mild to moderate peanut allergies who are willing to commit to the long-term treatment program under medical supervision.
What happens if a patient has an allergic reaction during Palforzia therapy?
If a patient experiences an allergic reaction, they should stop taking the dose and seek immediate medical attention. The healthcare provider will then adjust the treatment plan based on the severity of the reaction.
Can Palforzia be used to treat other food allergies besides peanuts?
Currently, Palforzia is only approved for treating peanut allergy. However, similar approaches are being explored and developed for other food allergies.
Try it live
Everything above runs in your browser — open Palforzia Oral Immunotherapy — 3D and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.
▶ Open Palforzia Oral Immunotherapy — 3D simulation